Ocular Therapeutix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Cash & Equivalents	197.57	104.06	165.93	229.82	56.2	60.68	43.15	34.66	31.01	37.62	Upgrade
Short-Term Investments	0	0	0	0	0	0	0	35.21	74.28	37.44	Upgrade
Cash & Cash Equivalents	197.57	104.06	165.93	229.82	56.2	60.68	43.15	69.87	105.29	75.06	Upgrade
Cash Growth	89.86%	-37.28%	-27.80%	308.93%	-7.38%	40.61%	-38.24%	-33.64%	40.28%	323.26%	Upgrade
Receivables	26.18	21.33	21.14	12.25	2.55	0.2	0.23	0.25	0.19	0.33	Upgrade
Inventory	2.31	1.97	1.25	1.2	0.95	0.22	0.12	0.11	0.13	0.13	Upgrade
Other Current Assets	6.18	2.26	2.99	2.89	0.47	-4.9	-0.16	-0.34	1.36	0.67	Upgrade
Total Current Assets	232.24	129.63	191.3	246.16	60.17	56.19	43.34	69.9	106.98	76.18	Upgrade
Property, Plant & Equipment	18.21	17.9	11.82	13.94	16.81	10.24	10.48	3.31	3.1	1.78	Upgrade
Other Long-Term Assets	1.61	1.76	1.76	1.76	1.76	6.61	1.61	1.73	0.23	0.23	Upgrade
Total Long-Term Assets	19.83	19.66	13.59	15.7	18.57	16.85	12.09	5.04	3.32	2.01	Upgrade
Total Assets	252.06	149.29	204.89	261.86	78.74	73.04	55.43	74.94	110.31	78.19	Upgrade
Accounts Payable	4.39	5.12	4.59	2.71	3.27	2.97	3.57	2.12	1.96	1.32	Upgrade
Deferred Revenue	14.39	13.96	13	12	0	0	0	0	0.04	0.19	Upgrade
Current Debt	1.59	1.6	1.62	9.65	1.13	0	5.55	1.55	0	1.35	Upgrade
Other Current Liabilities	14.53	10.71	7.12	2.31	7.64	6.19	4.31	4.64	3.38	3.02	Upgrade
Total Current Liabilities	34.9	31.4	26.34	26.66	12.03	9.16	13.43	8.3	5.38	5.87	Upgrade
Long-Term Debt	81.8	62.68	57.36	48.79	58.22	24.79	12.47	14.09	15.27	13.51	Upgrade
Other Long-Term Liabilities	44.23	19.83	33.19	110.31	12.12	3.22	3.39	0.54	0.07	0.11	Upgrade
Total Long-Term Liabilities	126.03	82.52	90.55	159.1	70.34	28.01	15.86	14.63	15.34	13.62	Upgrade
Total Liabilities	160.93	113.91	116.89	185.77	82.37	37.17	29.28	22.93	20.72	19.5	Upgrade
Total Debt	83.39	64.28	58.98	58.44	59.34	24.79	18.02	15.64	15.27	14.87	Upgrade
Debt Growth	29.72%	8.99%	0.93%	-1.52%	139.40%	37.59%	15.17%	2.43%	2.74%	505.01%	Upgrade
Retained Earnings	-697.58	-616.84	-545.8	-539.25	-383.62	-297.24	-237.27	-173.88	-129.18	-89.43	Upgrade
Comprehensive Income	0	0	0	0	0	0	0	-0.01	-0.07	0	Upgrade
Shareholders' Equity	91.13	35.38	88	76.1	-3.63	35.88	26.15	52.01	89.59	58.7	Upgrade
Net Cash / Debt	114.18	39.78	106.95	171.38	-3.14	35.89	25.14	54.23	90.02	60.19	Upgrade
Net Cash / Debt Growth	187.03%	-62.80%	-37.60%	-	-	42.78%	-53.65%	-39.76%	49.56%	294.02%	Upgrade
Net Cash Per Share	1.33	0.48	1.30	2.82	-0.07	0.94	0.87	2.19	3.87	5.65	Upgrade
Working Capital	197.34	98.23	164.96	219.5	48.14	47.03	29.91	61.6	101.61	70.31	Upgrade
Book Value Per Share	1.14	0.46	1.15	1.25	-0.08	0.94	0.91	2.10	3.85	5.51	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).